TY  - RPRT
TI  - Sustained efficacy of CRISPR-Cas13b gene therapy for FSHD is challenged by immune response to Cas13b
AU  - Rashnonejad, A.
AU  - Farea, M.
AU  - Chermahini, G. A.
AU  - COULIS, G.
AU  - Taylor, N.
AU  - Fowler, A.
AU  - Villalta, A.
AU  - King, O. D.
AU  - Harper, S. Q.
PY  - 2025
DO  - 10.1101/2024.12.18.629250
UR  - https://www.biorxiv.org/content/10.1101/2024.12.18.629250v1
ID  - 10.1101/2024.12.18.629250
ER  -